中文速读
本研究使用SAMP8小鼠模型,通过脑室内输注Entranster-in vivo转染试剂递送p40 siRNA,敲低IL-12/23 p40亚基,发现可减少脑内Aβ42水平、增加突触素和神经元密度,改善空间记忆,表明抑制IL-12/23信号可能成为阿尔茨海默病的治疗策略。
小鼠脑室内脑siRNA
IL12/23 p40 inhibition ameliorates Alzheimer’s disease-associated neuropathology and spatial memory in SAMP8 mice
Meng-Shan Tan 1 , Jin-Tai Yu, Teng Jiang, Xi-Chen Zhu, Hua-Shi Guan, Lan Tan
Affiliation
- 1 College of Medicine and Pharmaceutics, Ocean University of China, Qingdao, China.
Abstract
Progressively increased proinflammatory status is a major characteristic of the aging process and associated with age-related diseases such as Alzheimer’s diseases (AD). However, the regulation and role of common proinflammatory cytokines, including interleukin-12 (IL-12) and IL-23, in the aged brain are still unclear. Using the senescence-accelerated mouse prone-8 (SAMP8) model, we screened the cerebral expression of IL-12/23 in 3-, 7-, and 11-month-old mice and observed that their levels in the brain were upregulated during aging. To further examine whether the heightened activation of inflammatory cytokines may contribute to age-related brain dysfunction, we employed direct in vivo infusion of nonviral small interfering RNA (siRNA) to knock down the common IL-12/23 signaling subunit p40 in the brain. We found that these p40-deficient mice had significantly decreased cerebral amyloid-β levels, reduced synaptic and neuronal loss, and reversed cognitive impairments. Furthermore, in vivo delivery of a neutralizing p40-specific antibody likewise ameliorated AD-associated pathology and cognitive deficits in SAMP8 mice. Thus, our data indicate that the upregulated cerebral IL-12/23 during aging is involved in age-associated brain dysfunction and point to the modulation of IL-12/23 signaling molecule p40 as a promising strategy for the development of an AD therapy.
Keywords: Aging; Alzheimer’s disease; IL-12; IL-23; SAMP8; amyloid-β; memory impairment.
RNA体内转染Entranster™-in vivo 已有 503 篇已发表文献
同类研究
- Sci Adv. 2026 Oct 28;12(44):eaee0110.doi: 10.1126/sciadv.aee0110. An oxidized ribonucleotide 8-oxoGTP drives neuroinflam…
- Cell Biol Toxicol. 2026 Aug 3;42(1):127.doi: 10.1007/s10565-026-10239-3. METTL3-mediated m6A modification targets the re…
- Bioact Mater. 2026 Jul 12;66:487-507.doi: 10.1016/j.bioactmat.2026.06.047. Targeting ROAM1 with UDP-GlcNAc nanosheets se…
- Transl Psychiatry. 2026 Jul 1.doi: 10.1038/s41398-026-04221-0. Natural flavonoid dihydroquercetin blocks Trim14-JAK1-STA…
- Front Cell Dev Biol. 2026 Jun 17:14:1677758.doi: 10.3389/fcell.2026.1677758. Rare variants of GPSM2 associated with aneu…